Document is current
Any future updates will be listed below
-
Authors
Ogier du Terrail, Jean https://orcid.org/0000-0001-6320-819X
Leopold, Armand https://orcid.org/0000-0002-5909-2689
Joly, Clément
Béguier, Constance
Andreux, Mathieu https://orcid.org/0000-0001-5778-9979
Maussion, Charles
Schmauch, Benoît https://orcid.org/0000-0002-9478-6395
Tramel, Eric W.
Bendjebbar, Etienne
Zaslavskiy, Mikhail
Wainrib, Gilles
Milder, Maud
Gervasoni, Julie
Guerin, Julien https://orcid.org/0000-0002-3024-8483
Durand, Thierry https://orcid.org/0000-0003-3861-8394
Livartowski, Alain
Moutet, Kelvin
Gautier, Clément
Djafar, Inal
Moisson, Anne-Laure
Marini, Camille
Galtier, Mathieu
Balazard, Félix
Dubois, Rémy
Moreira, Jeverson https://orcid.org/0000-0003-3478-7158
Simon, Antoine
Drubay, Damien https://orcid.org/0000-0002-9997-9727
Lacroix-Triki, Magali https://orcid.org/0000-0002-6641-8536
Franchet, Camille
Bataillon, Guillaume
Heudel, Pierre-Etienne https://orcid.org/0000-0002-2155-549X
-
Funding
Funding for this research was provided by:
Owkin Inc.
Institut Curie
Centre Léon Bérard
Institut Gustave Roussy
Oncopole Toulouse
- License Information
-
More Information
Article History
Received: 20 May 2021
Accepted: 23 November 2022
First Online: 19 January 2023
Competing interests
: The authors declare the existence of a financial competing interest. As described in the Acknowledgements section, this work received the financial support of the French Banque Publique d’Investissement (BPI) through the HealthChain project ( ). Some authors are or were employed by Owkin, Inc. during their time on the project (J.O.d.T., C.B., M.A., C. Maussion, B.S., E.B., M.Z., G.W., K.M., C.G., I.D., A.- L.M., C. Marini, M.G., J.M., R.D., A.S. and F.B.). In addition, G.W. is the cofounder of Owkin, Inc. P.E.H. reports grants, personal fees and nonfinancial support from Pfizer; grants and nonfinancial support from Novartis; grants and nonfinancial support from Roche; grants, personal fees and nonfinancial support from AstraZeneca; personal fees and nonfinancial support from Mylan; grants, personal fees, and nonfinancial support from Pierre Fabre; personal fees and nonfinancial support from Amgen; and personal fees and nonfinancial support from Seagen outside the submitted work.
